0000899243-21-028253.txt : 20210713 0000899243-21-028253.hdr.sgml : 20210713 20210713200023 ACCESSION NUMBER: 0000899243-21-028253 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210712 FILED AS OF DATE: 20210713 DATE AS OF CHANGE: 20210713 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tehrani Ali CENTRAL INDEX KEY: 0001761853 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38068 FILM NUMBER: 211089060 MAIL ADDRESS: STREET 1: 1385 WEST 8TH AVENUE STREET 2: SUITE 540 CITY: VANCOUVER STATE: A1 ZIP: V6H3V9 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zymeworks Inc. CENTRAL INDEX KEY: 0001403752 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 540-1385 WEST 8TH AVENUE CITY: Vancouver STATE: A1 ZIP: V6H 3V9 BUSINESS PHONE: (604) 678-1388 MAIL ADDRESS: STREET 1: 540-1385 WEST 8TH AVENUE CITY: Vancouver STATE: A1 ZIP: V6H 3V9 FORMER COMPANY: FORMER CONFORMED NAME: Zymeworks Inc DATE OF NAME CHANGE: 20070620 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-07-12 0 0001403752 Zymeworks Inc. ZYME 0001761853 Tehrani Ali C/O ZYMEWORKS INC. 1385 WEST 8TH AVENUE, SUITE 540 VANCOUVER A1 V6H 3V9 BRITISH COLUMBIA, CANADA 1 1 0 0 Chief Executive Officer Common Shares 2021-07-12 4 M 0 12669 4.3062 A 272994 D Common Shares 2021-07-12 4 S 0 12669 36.1224 D 260325 D Common Shares 55511 I Held by spouse Stock Option (Right to Buy) 4.3062 2021-07-12 4 M 0 12669 0.00 D 2013-01-01 2022-01-01 Common Shares 12669 44991 D Pursuant to a 10b5-1 plan entered into May 13, 2021. The exercise price of the stock option is CAD5.37. The U.S. dollar equivalent of the exercise price is $4.3062 using the Bank of Canada exchange rate for July 12, 2021 (CAD1.00 = $0.8019). The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.0649 to $36.5902, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 12, 2021 at each separate price. Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date of January 1, 2012 and (ii) remainder of underlying shares in 36 equal monthly installments on the last day of month following first anniversary of grant date. /s/ Daniel Dex, Attorney-in-Fact 2021-07-13